EUVIMEDEUVIMED entdecken
Crossref

A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3

Isabelle Côté, Victoria Hodgkinson iD, Marianne Nury, Louis Bastenier-Boutin, Xavier Rodrigue iD

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2025

DOI: 10.1017/cjn.2024.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2025. Verfasst von Isabelle Côté und 4 weiteren Autor:innen. Beteiligte Einrichtung: Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN), Centre intégré universitaire de santé et de services sociaux du Sag…. Hauptthemen laut MEDLINE: Oligonucleotides, Spinal Muscular Atrophies of Childhood. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spinal muscular atrophy (SMA) is a progressive genetic disorder characterized by muscle weakness ultimately leading to pulmonary impairments that can be fatal. The recent approval of nusinersen, a disease-modifying therapy, substantially changed the prognosis for patients, particularly in children. However, real-world evidence about its long-term effectiveness in adults remains limited. This study aimed to document longitudinal data on motor function, pulmonary function and patient-reported outcome measures of Canadian adults with SMA type 2 and 3 treated with nusinersen.

Methods

Outcomes from 17 patients were collected at the Institut de réadaptation en déficience physique de Québec during routine clinical visits over 36 months post nusinersen treatment, using the Hammersmith Functional Motor Scale Expanded for SMA (HFMSE), Revised Upper Limb Module (RULM), 6-Minute Walk Test (6MWT), Children’s Hospital of Philadelphia Adult Test of Neuromuscular Disorders (CHOP-ATEND), SMA functional rating scale (SMAFRS), pulmonary function testing and subjective changes reported by patients.

Results

After 36 months, 9 patients showed motor function improvement. Changes beyond the minimal clinically important difference were seen for four patients on the HFMSE, four patients on the RULM and five patients on the 6MWT. Pulmonary function remained stable for most subjects. Subjective positive changes were reported in 88% of patients and five patients showed improvement in the SMAFRS.

Conclusion

This real-world study demonstrates the positive effects of nusinersen in adults with SMA types 2 and 3. Although stabilizing the patient’s condition is considered therapeutic success, this study shows an improvement in motor function and subjective gains in several patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligonucleotidesSpinal Muscular Atrophies of ChildhoodHumansMaleFemaleAdultMiddle AgedYoung AdultTreatment OutcomeAdolescentLongitudinal StudiesPatient Reported Outcome MeasuresCanada

Stichwörter der Autor:innen

NusinersenPROM (Patient Reported Outcome Measures)motor functionpulmonary functionreal-world dataspinal muscular atrophy

Substanzen

nusinersenOligonucleotides

Autor:innen und Institutionen

  • Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN), Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-St-Jean, Saguenay, QC, Canada.
  • Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
  • Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale, Québec, QC, Canada.
  • Centre interdisciplinaire de recherche en réadaptation et intégration sociale (CIRRIS), Institut de réadaptation en déficience physique de Québec (IRDPQ), Québec, QC, Canada.

ORCID-Profile: Victoria Hodgkinson, Xavier Rodrigue

Zitieren

APA

Côté, I., Hodgkinson, V., Nury, M., Bastenier-Boutin, L., & Rodrigue, X. (2025). A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2024.49

Vancouver

Côté I, Hodgkinson V, Nury M, Bastenier-Boutin L, Rodrigue X. A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2025. doi:10.1017/cjn.2024.49

BibTeX
@article{Ct2025,
  author = {Côté, Isabelle and Hodgkinson, Victoria and Nury, Marianne and Bastenier-Boutin, Louis and Rodrigue, Xavier},
  title = {A Real-World Study of Nusinersen Effects in Adults with Spinal Muscular Atrophy Type 2 and 3},
  journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year = {2025},
  doi = {10.1017/cjn.2024.49}
}
Kostenlos starten →